Avantra Family Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
868
+33
+4% +$33.7K 0.66% 45
2026
Q1
$768K Sell
835
-172
-17% -$174K 0.57% 54
2025
Q4
$1.08M Sell
1,007
-16
-2% -$15.3K 0.79% 39
2025
Q3
$781K Buy
1,023
+1
+0.1% +$744 0.58% 49
2025
Q2
$797K Sell
1,022
-241
-19% -$187K 0.66% 42
2025
Q1
$1.04M Sell
1,263
-17
-1% -$14.1K 1% 25
2024
Q4
$988K Buy
+1,280
New +$1.06M 0.92% 27

Other funds holding LLY

Avantra Family Wealth's LLY Position: Q2 2026 in Review

Avantra Family Wealth increased its Eli Lilly (LLY) stake by 4% in Q2 2026, buying an estimated $33.7K and bringing the position to 868 shares worth $1.04M. The position accounts for 0.66% of the portfolio, ranked #45.

Avantra Family Wealth first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.08M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Avantra Family Wealth held 868 shares of Eli Lilly worth $1.04M as of Q2 2026.
  • Avantra Family Wealth bought 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
  • Eli Lilly made up 0.66% of Avantra Family Wealth's portfolio in Q2 2026, its #45 holding.
  • Avantra Family Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Avantra Family Wealth's Eli Lilly position peaked at $1.08M in Q4 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Avantra Family Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.